Syros Pharmaceuticals Inc (SYRS) is around the middle of the Biotechnology industry according to InvestorsObserver. SYRS received an overall rating of 42, which means that it scores higher than 42 percent of all stocks. Syros Pharmaceuticals Inc also achieved a score of 41 in the Biotechnology industry, putting it above 41 percent of Biotechnology stocks. Biotechnology is ranked 40 out of the 148 industries.
SYRS has an Overall Score of 42. Find out what this means to you and get the rest of the rankings on SYRS!